Page last updated: 2024-09-03

gefitinib and cgp 52411

gefitinib has been researched along with cgp 52411 in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(cgp 52411)
Trials
(cgp 52411)
Recent Studies (post-2010) (cgp 52411)
5,2315662,91949017

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)cgp 52411 (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klar, U; Lichtner, RB; Menrad, A; Schneider, MR; Sommer, A1

Other Studies

1 other study(ies) available for gefitinib and cgp 52411

ArticleYear
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
    Cancer research, 2001, Aug-01, Volume: 61, Issue:15

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Division; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gefitinib; Humans; Kinetics; Ligands; Lung Neoplasms; Mammary Neoplasms, Experimental; Phthalimides; Quinazolines; Rats; Signal Transduction; Tumor Cells, Cultured

2001